Stay updated on PF-06438179 in RA Clinical Trial

Sign up to get notified when there's something new on the PF-06438179 in RA Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PF-06438179 in RA Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    - Removed the core topic 'Rheumatoid arthritis' and the related topic link 'MedlinePlus Genetics' from the page.
    Difference
    0.1%
    Check dated 2025-12-12T16:32:32.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The page now lists related topics 'Rheumatoid arthritis' and 'MedlinePlus Genetics' in the related topics section.
    Difference
    0.1%
    Check dated 2025-12-05T10:24:47.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    - Revision updated from v3.3.1 to v3.3.2 on the Study Details page.
    Difference
    0.0%
    Check dated 2025-11-28T07:14:29.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Publication notes now clarify PubMed auto-filled publications may not be about the study, and the page revision is updated to v3.3.1.
    Difference
    0.1%
    Check dated 2025-11-21T02:15:56.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Added related topics Rheumatoid arthritis and MedlinePlus Genetics. Removed the government funding notice about updates and NIH operating status.
    Difference
    0.2%
    Check dated 2025-11-13T22:41:07.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The study locations list appears updated/expanded, with no changes to the study design, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-10-30T13:22:34.000Z thumbnail image

Stay in the know with updates to PF-06438179 in RA Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PF-06438179 in RA Clinical Trial page.